Achim A Jungbluth Selected Research

Antigens

10/2008	Cancer testis antigen expression in gastrointestinal stromal tumors: new markers for early recurrence.
01/2008	Recognition of a ubiquitous self antigen by prostate cancer-infiltrating CD8+ T lymphocytes.
01/2008	Cancer-testis (CT) antigen expression in medulloblastoma.
11/2007	NY-BR-1 protein expression in breast carcinoma: a mammary gland differentiation antigen as target for cancer immunotherapy.
06/2007	The differentiation antigen NY-BR-1 is a potential target for antibody-based therapies in breast cancer.
02/2007	Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation.
01/2007	Expression of the cancer/testis antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM)--correlation with prognostic factors.
01/2007	Expression of cancer-testis (CT) antigens in placenta.
01/2007	Cancer/testis (CT) antigens are expressed in fetal ovary.
09/2006	Cancer-testis antigens: expression and correlation with survival in human urothelial carcinoma.
02/2006	Tumor antigen expression in melanoma varies according to antigen and stage.
01/2006	NY-ESO-1: review of an immunogenic tumor antigen.
01/2006	Physical interaction of two cancer-testis antigens, MAGE-C1 (CT7) and NY-ESO-1 (CT6).
01/2006	Generation of monoclonal antibodies to cancer/testis (CT) antigen CT10/MAGE-C2.
07/2005	The cancer-testis antigens CT7 (MAGE-C1) and MAGE-A3/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferation.
04/2005	Expression of MHC class I, MHC class II, and cancer germline antigens in neuroblastoma.
01/2005	Expression of cancer-testis antigens in endometrial carcinomas using a tissue microarray.
12/2004	Immunohistochemical and molecular analysis of human melanomas for expression of the human cancer-testis antigens NY-ESO-1 and LAGE-1.
12/2004	Expression and significance of cancer testis antigens in primary mucosal melanoma of the head and neck.
11/2004	Cancer/testis antigen expression and autologous humoral immunity to NY-ESO-1 in gastric cancer.
10/2004	SCP-1 cancer/testis antigen is a prognostic indicator and a candidate target for immunotherapy in epithelial ovarian cancer.
12/2003	Primary malignant melanoma of the oesophagus: a clinical and pathological study with emphasis on the immunophenotype of the tumours for melanocyte differentiation markers and cancer/testis antigens.
10/2003	SSX antigens as tumor vaccine targets in human sarcoma.
09/2003	NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer.
07/2003	Expression of cancer/testis (CT) antigens MAGE-A1, MAGE-A3, MAGE-A4, CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of disease.
10/2002	Cancer/testis antigens: an expanding family of targets for cancer immunotherapy.
02/2002	MAGE antigen expression in monophasic and biphasic synovial sarcoma.

Articles by Research Topic

Disease

19	Testicular Neoplasms (Testicular Cancer) 10/2008 - 10/2002
10	Melanoma (Melanoma, Malignant) 05/2008 - 10/2002
10	Neoplasms (Cancer) 11/2007 - 10/2002
2	Carcinoma (Carcinomatosis) 11/2007 - 09/2006
2	Multiple Myeloma 02/2007 - 07/2005
2	Ovarian Neoplasms (Ovarian Cancer) 10/2004 - 09/2003
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 10/2008
1	Neoplasm Metastasis (Metastasis) 05/2008
1	Prostatic Neoplasms (Prostate Cancer) 01/2008
1	Medulloblastoma 01/2008
1	Small Cell Carcinoma 10/2007
1	Breast Neoplasms (Breast Cancer) 06/2007
1	Neuroblastoma 04/2005
1	Endometrial Neoplasms (Endometrial Cancer) 01/2005
1	Stomach Neoplasms (Stomach Cancer) 11/2004
1	Melanosis (Freckles) 03/2004
1	Tumor Lysis Syndrome 03/2004
1	Urinary Bladder Neoplasms (Bladder Cancer) 12/2003
1	Sarcoma (Soft Tissue Sarcoma) 10/2003
1	Nevus (Nevi) 10/2002
1	Synovial Sarcoma (Synovioma) 02/2002

Drug/Important Bio-Agent (IBA)

27	AntigensIBA 10/2008 - 02/2002
2	Epidermal Growth Factor Receptor (EGF Receptor)IBA 09/2005 - 01/2003
2	Differentiation AntigensIBA 12/2003 - 10/2002
1	temozolomide (Temodar)FDA Link 05/2008
1	Indicators and Reagents (Reagents)IBA 05/2008
1	monoclonal antibody Hu3S193IBA 10/2007
1	pullulanIBA 01/2007
1	CholesterolIBA 01/2007
1	ClusterinIBA 09/2006
1	Monoclonal AntibodiesIBA 01/2006
1	Glycoproteins (Glycoprotein)IBA 01/2006
1	monoclonal antibody 806IBA 09/2005
1	SCP 1IBA 10/2004
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 12/2003

Therapy/Procedure

5	Immunotherapy 11/2007 - 10/2002
1	Stem Cell Transplantation 02/2007
1	Heterologous Transplantation (Xenotransplantation) 09/2005
1	Drug Therapy (Chemotherapy) 03/2004